Van Cauter E, Mestrez F, Sturis J, Polonsky K S
Department of Medicine, University of Chicago, Illinois 60637.
Diabetes. 1992 Mar;41(3):368-77. doi: 10.2337/diab.41.3.368.
Insulin secretion rates can be accurately estimated from plasma C-peptide levels with a two-compartment model for C-peptide distribution and degradation. In previous studies, the kinetic parameters of C-peptide clearance were derived in each subject from the decay curve observed after bolus intravenous injection of biosynthetic human C-peptide. To determine whether standard parameters for C-peptide clearance could be defined and used to calculate insulin secretion without obtaining a decay curve in each subject, we analyzed 200 decay curves of biosynthetic human C-peptide obtained in normal, obese, and non-insulin-dependent diabetes mellitus subjects studied in our laboratory. This analysis showed that the volume of distribution and kinetic parameters of C-peptide distribution and metabolism vary by less than 30% in a population highly heterogeneous in terms of age, sex, degree of obesity, and degree of glucose tolerance. The volume of distribution correlated with the degree of obesity as quantified by body surface area (BSA). This dependence of C-peptide distribution volume on BSA was more marked in men than in women. The long half-life was slightly longer in elderly subjects than in younger adults. When effects of BSA, sex, and age were taken into account, the parameters of C-peptide kinetics were very similar in normal, obese, and diabetic subjects. Based on these findings, a simple procedure to derive standard parameters for C-peptide clearance taking into account degree of obesity, sex, and age was defined. These standard parameters resulted in estimations of mean insulin secretion rates, which differed in each subject by only 10-12% from those obtained with individual parameters. The approach of using standard rather than individual parameters did not systematically underestimate or overestimate insulin secretion so that group values for the fasting secretion rate, the mean 24-h secretion rate, and the number and the amplitude of secretory pulses obtained with standard parameters differed by only 1-2% from the values obtained with individual parameters. Furthermore, the accuracy of measurements based on standard parameters was not different from that associated with replicate determinations of the parameters of C-peptide clearance in the same subject. We conclude that it is possible to estimate insulin secretion rates from plasma C-peptide levels with standard parameters for C-peptide clearance rather than individually derived parameters without significant loss of accuracy.
通过C肽分布和降解的两室模型,可从血浆C肽水平准确估算胰岛素分泌率。在先前的研究中,C肽清除的动力学参数是在每名受试者静脉注射生物合成人C肽推注后,根据观察到的衰减曲线得出的。为了确定是否可以定义C肽清除的标准参数并用于计算胰岛素分泌,而无需在每名受试者中获取衰减曲线,我们分析了在我们实验室研究的正常、肥胖和非胰岛素依赖型糖尿病受试者中获得的200条生物合成人C肽的衰减曲线。该分析表明,在年龄、性别、肥胖程度和糖耐量程度高度异质的人群中,C肽分布和代谢的分布容积和动力学参数变化小于30%。分布容积与通过体表面积(BSA)量化的肥胖程度相关。C肽分布容积对BSA的这种依赖性在男性中比在女性中更明显。老年受试者的长半衰期比年轻成年人略长。当考虑到BSA、性别和年龄的影响时,正常、肥胖和糖尿病受试者中C肽动力学参数非常相似。基于这些发现,定义了一种考虑肥胖程度、性别和年龄来推导C肽清除标准参数的简单程序。这些标准参数得出的平均胰岛素分泌率估计值,在每名受试者中与使用个体参数获得的值仅相差10 - 12%。使用标准参数而非个体参数的方法不会系统性地低估或高估胰岛素分泌,因此使用标准参数获得的空腹分泌率、平均24小时分泌率以及分泌脉冲的数量和幅度的组值与使用个体参数获得的值仅相差1 - 2%。此外,基于标准参数的测量准确性与同一受试者中C肽清除参数重复测定的准确性没有差异。我们得出结论,使用C肽清除的标准参数而非个体推导的参数,从血浆C肽水平估算胰岛素分泌率是可行的,且不会显著损失准确性。